Patricia M Cameron

Title: Patricia M Cameron: Innovator in Enzyme and Interleukin Research

Introduction

Patricia M Cameron is a notable inventor based in Titusville, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of enzymes and the purification of interleukin species. With a total of 2 patents, her work has implications for both pharmaceutical and therapeutic applications.

Latest Patents

Cameron's latest patents include a methylating enzyme derived from Streptomyces MA6858. This enzyme, known as 31-O-desmethyl-FK-506 O-methyltransferase (FKMT), is capable of specifically methylating the C-31 hydroxy group in various compounds. The enzyme can be isolated from a FK-506 producing microorganism, and its active form can be employed in the presence of S-adenosyl methionine (SAM) to prepare derivatives of 31-O-desmethyl FK-506 and related compounds. Another significant patent involves the purification of human interleukin-1 species through a rapid chromatographic process. This method allows for the separation and purification of IL-1 charged species, resulting in homogenously pure forms of these important biomolecules.

Career Highlights

Cameron is currently associated with Merck & Company, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of enzyme functions and interleukin purification techniques.

Collaborations

Throughout her career, Cameron has collaborated with esteemed colleagues, including Jack A Schmidt and Guadalupe A Limjuco. These partnerships have enhanced her research and contributed to the successful outcomes of her projects.

Conclusion

Patricia M Cameron's innovative work in enzyme and interleukin research showcases her dedication to advancing biochemistry. Her patents reflect her significant contributions to the field, and her collaborations further highlight the importance of teamwork in scientific discovery.